Stocks
BlossomHill Therapeutics, Inc.BLSM
NASDAQHealthcareBiotechnology$15.47
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing small molecule therapeutics for cancer and other diseases. Focuses on targeting resistance mechanisms in oncology, with a pipeline of precision medicines. Investors track it for its progress in next-generation kinase inhibitors and other targeted therapies.
52W Range: $12.93-$27.99
Congressional Interest in BlossomHill Therapeutics, Inc. (BLSM)
No congressional trades have been disclosed for BlossomHill Therapeutics, Inc. (BLSM) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading BLSM?
No congressional trades found for this stock.